GlassScriptPhysician profile
Noel I Rubio
NPI 1922036797
$2,511.30
in general payments reported to CMS, 2019-2025
14 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.81 · 2021: $32.21 · 2022: $39.30 · 2024: $836 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $440.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $432.58 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $316.54 | 2024-2025 | |
| Lilly USA, LLC | $276.29 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $262.46 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $233.47 | 2024-2025 | Repatha, Repatha, Krystexxa |
| Corcept Therapeutics | $129.67 | 2024-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $96.04 | 2024-2025 | Farxiga |
| Exact Sciences Corporation | $90.55 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dexcom, INC. | $72.80 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $63.61 | 2025 | Gvoke Hypopen |
| Astellas Pharma US INC | $47.00 | 2024 | Veozah |
| Kowa Pharmaceuticals America, INC. | $32.11 | 2025 | Zoryve |
| Cranial Technologies, INC | $18.00 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Rubio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.